CoChat
Sign Up
Cited by 690Antifungal resistance and susceptibilityFungal and yeast genetics researchBacterial biofilms and quorum sensing

The DOI matches its Crossref record; 163 of the 163 references it cites were found in a registry or an index.

Candida Biofilms: Threats, Challenges, and Promising Strategies

Open access
Cavalheiro, Mafalda, Teixeira, Miguel Cacho·2018·Frontiers in Medicine
DOI 10.3389/fmed.2018.00028PMC PMC5816785
Open this paper in CoChat — free accountOpen PDF

Abstract

Candida species are fungal pathogens known for their ability to cause superficial and systemic infections in the human host. These pathogens are able to persist inside the host due to the development of pathogenicity and multidrug resistance traits, often leading to the failure of therapeutic strategies. One specific feature of Candida species pathogenicity is their ability to form biofilms, which protects them from external factors such as host immune system defences and antifungal drugs. This review focuses on the current threats and challenges when dealing with biofilms formed by Candida albicans, Candida glabrata, Candida tropicalis and Candida parapsilosis, highlighting the differences between the four species. Biofilm characteristics depend on the ability of each species to produce extracellular polymeric substances (EPS) and display dimorphic growth, but also on the biofilm substratum, carbon source and other factors. Additionally, the transcriptional control over processes like adhesion, biofilm formation, filamentation and EPS production displays great complexity and diversity within pathogenic yeasts of the Candida genus. These differences not only have implications in the persistence of colonization and infections, but also on antifungal resistance typically found in Candida biofilm cells, potentiated by EPS, that functions as a barrier to drug diffusion, and by the overexpression of drug resistance transporters. The ability to interact with different species in in vivo Candida biofilms is also a key factor to consider when dealing with this problem. Despite many challenges, the most promising strategies that are currently available or under development to limit biofilm formation or to eradicate mature biofilms are discussed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fmed.2018.00028

Cites

163 of 163 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 163 references

Cited by

Sorted by citations

Items 501–600 of 690

Related

See all

Metadata

Authors
Cavalheiro, M., & Teixeira, M. C.
Affiliations
University of Lisbon (PT)
Corresponding author
Teixeira, Miguel Cacho
ORCID
Venue
Frontiers in Medicine
Publisher
Frontiers Media SA
Published
2018-02-13
Volume
5
Pages
28-28
ISSN
2296-858X (ISSN-L)
DOI
10.3389/fmed.2018.00028
PMC
PMC5816785
OpenAlex
W2792847166
Cited by
690
References
163
Citations by year
2026: 57 · 2025: 85 · 2024: 96 · 2023: 103 · 2022: 114 · 2021: 94 · 2020: 87 · 2019: 38 · 2018: 14
FWCI
8.53
Type
journal article
Language
en
Open access
Licence
Locations
  • Frontiers in Medicine (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
Fundação para a Ciência e a Tecnologia (PTDC/BBB-BIO/4004/2014, SFRH/BD/116946/2016, UID/BIO/04565/2013)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
Keywords
Candida biofilms, Candida albicans, Candida glabrata, Candida tropicalis, Candida parapsilosis, extracellular polymeric substances, antifungal resistance, filamentation, fungal pathogenicity, host-pathogen interaction

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review